Fibrinogen as a Predictor of Early Neurological Deterioration in Acute Ischemic Stroke - Evidence From the Indian Population
- PMID: 36779168
- PMCID: PMC9909079
- DOI: 10.1177/11795735231156349
Fibrinogen as a Predictor of Early Neurological Deterioration in Acute Ischemic Stroke - Evidence From the Indian Population
Abstract
Background: Early neurological deterioration (END) is a common occurrence in ischemic stroke and contributes significantly to poor outcomes. Although multiple factors that predict END have already been identified, the role of fibrinogen - a key component of the coagulation pathway, is controversial.
Objective: To assess the role of fibrinogen in predicting END and poor hospital outcome in patients with acute ischemic stroke.
Design: Single-centre prospective observational study.
Methods: 141 patients with acute ischemic stroke were analyzed in this prospective observational study from a single tertiary-care hospital in East India. END was defined as a worsening of ≥2 points on the National Institutes of Health Stroke Scale (NIHSS) within 7 days of admission. A score of 3-5 on the Modified Rankin Scale (mRS), a stroke recurrence event or death during hospital stay was considered poor hospital outcome. We performed univariate analysis using age, sex, body-mass index (BMI), hypertension, diabetes, NIHSS scores, stroke etiology, blood glucose and lipid parameters and plasma fibrinogen to develop a logistic regression model to establish the independent predictors of END and poor outcome.
Results: Age (Odds Ratio (OR) 1.034 [95% CI 1.001-1.069], P = .046), NIHSS score at admission (OR 1.152 [95% CI 1.070-1.240], P < .001) and fibrinogen (OR 1.011 [95%CI 1.006-1.015], P < .001) were independent predictors of END in patients with acute ischemic stroke. Factors independently associated with poor outcome were NIHSS score at admission (OR 1.257 [95% CI 1.150-1.357], P < .001), fasting plasma glucose (OR 1.007 [95% CI 1.001-1.013], P = .020), and fibrinogen [OR 1.004 [95% CI 1.000-1.007], P = .038).
Conclusion: The significant role of fibrinogen in determining neurological worsening and subsequent poor outcomes in patients with acute ischemic stroke may help in early prognostication and guided therapeutic interventions.
Keywords: acute ischemic stroke; early neurological deterioration; fibrinogen; national institutes of health stroke scale; outcome.
© The Author(s) 2023.
Conflict of interest statement
AS: Conceptualization, Methodology, Supervision, Validation, Visualization, Writing – reviewing and editing. DJ: Data curation, Formal analysis, Investigation, Resources, Software, Validation, Visualization. RP: Data curation, Formal analysis, Investigation, Validation, Writing – reviewing and editing. RK: Investigation, Methodology, Validation, Writing – reviewing and editing. RTG: Conceptualization, Supervision. CBS: Conceptualization, Supervision The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
References
-
- Adams HP, Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35-41. - PubMed
-
- Huang ZX, Wang QZ, Dai YY, et al. Early neurological deterioration in acute ischemic stroke: A propensity score analysis. J Chin Med Assoc. 2018;81(10):865-870. - PubMed
-
- Dávalos A, Cendra E, Teruel J, et al. Deteriorating ischemic stroke: risk factors and prognosis. Neurology. 1990;40(12):1865-1869. - PubMed
-
- Peycheva M, Deneva T, Zahariev Z. The role of fibrinogen in acute ischaemic stroke. Neurol Neurochir Pol. 2021;55(1):74-80. - PubMed